Parkinson's disease (PD) is one of the most common neurodegenerative diseases. Recent
data highlight similarities between neurodegenerative diseases, including PD and type 2 …

Neurodegenerative diseases are often referred to as diseases of old age, and with the aging
population, they are gaining scientific and medical interest. Environmental stressors, most …

The intricate spatial configurations of brain networks offer essential insights into
understanding the specific patterns of brain abnormalities and the underlying biological …

Although conventional intervention to microglia can mitigate neuroinflammation in the short
term, immune disorders by peripheral inflammatory cells can infiltrate continuously, resulting …

Abnormal behavior of α-synuclein and prion proteins is the hallmark of Parkinson's disease
(PD) and prion illnesses, respectively, being complex neurological disorders. A primary …

There are currently no disease-modifying therapies for Parkinson's disease (PD), a
progressive neurodegenerative disorder associated with dopaminergic neuronal loss. There …

Semaglutide (SEM), a glucagon-like peptide-1 receptor agonist, has garnered increasing
interest for its potential therapeutic effects in neurodegenerative disorders such as …

Parkinson's disease is a neurodegenerative condition defined by the progressive death of
dopaminergic neurons in the brain. The diagnosis of Parkinson's disease often uses time …

Dopamine, a neurotransmitter with multiple functions in the brain. The abnormal of
dopamine levels are generally considered to be associated with various nervous system …

Dopaminergic degeneration is a central feature of Parkinson's disease (PD), but glial
dysfunction may accelerate or trigger neuronal death. In fact, astrocytes play a key role in the …